000 | 01172 a2200349 4500 | ||
---|---|---|---|
005 | 20250517235038.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1792-0981 | ||
024 | 7 |
_a10.3892/etm.2018.6459 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJiang, Nan | |
245 | 0 | 0 |
_aNovel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs. _h[electronic resource] |
260 |
_bExperimental and therapeutic medicine _cSep 2018 |
||
300 |
_a2183-2192 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
700 | 1 | _aLin, Jing-Jing | |
700 | 1 | _aWang, Jun | |
700 | 1 | _aZhang, Bei-Ning | |
700 | 1 | _aLi, Ao | |
700 | 1 | _aChen, Zheng-Yang | |
700 | 1 | _aGuo, Song | |
700 | 1 | _aLi, Bin-Bin | |
700 | 1 | _aDuan, Yu-Zhong | |
700 | 1 | _aYan, Ru-Yi | |
700 | 1 | _aYan, Hong-Feng | |
700 | 1 | _aFu, Xiao-Yan | |
700 | 1 | _aZhou, Jin-Lian | |
700 | 1 | _aYang, He-Ming | |
700 | 1 | _aCui, Yan | |
773 | 0 |
_tExperimental and therapeutic medicine _gvol. 16 _gno. 3 _gp. 2183-2192 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3892/etm.2018.6459 _zAvailable from publisher's website |
999 |
_c28807253 _d28807253 |